Eastwood Bio-Medical Canada Inc.
EBM.V
TSX
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 96.30% | -25.74% | 102.23% | -33.60% | -45.78% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 96.30% | -25.74% | 102.23% | -33.60% | -45.78% |
| Cost of Revenue | -22.74% | -9.69% | 18.41% | -32.70% | -22.84% |
| Gross Profit | 221.67% | -31.37% | 172.21% | -34.00% | -58.71% |
| SG&A Expenses | -10.62% | -8.98% | 64.24% | -27.84% | -2.07% |
| Depreciation & Amortization | -- | -75.63% | -100.00% | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -7.75% | -20.99% | 35.71% | -35.57% | -16.76% |
| Operating Income | 65.67% | -6.02% | 70.76% | 39.51% | -18.58% |
| Income Before Tax | 56.07% | 47.24% | 51.49% | 49.94% | -15.12% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 56.07% | 47.24% | 51.49% | 49.94% | -15.12% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 56.07% | 47.24% | 51.49% | 49.94% | -15.12% |
| EBIT | 65.67% | -6.02% | 70.76% | 39.51% | -18.58% |
| EBITDA | 73.51% | -510.00% | 61.05% | 16.21% | -55.95% |
| EPS Basic | 56.25% | 50.00% | 52.94% | 50.00% | -14.29% |
| Normalized Basic EPS | 60.00% | 66.67% | 50.00% | 50.00% | -11.11% |
| EPS Diluted | 56.25% | 50.00% | 52.94% | 50.00% | -14.29% |
| Normalized Diluted EPS | 60.00% | 66.67% | 50.00% | 50.00% | -11.11% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |